Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Bumbaca Yadav D"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ayalon G; Department of Neuroscience, Genentech Inc., San Francisco, CA 94080, USA., Lee SH; Department of Neuroscience, Genentech Inc., San Francisco, CA 94080, USA., Adolfsson O; AC Immune SA, EPFL Innovation Park, Building B, CH-1015 Lausanne, Switzerland., Foo-Atkins C; Project Team Leadership, Genentech Inc., San Francisco, CA 94080, USA., Atwal JK; Department of Neuroscience, Genentech Inc., San Francisco, CA 94080, USA., Blendstrup M; Department of Early Clinical Development, Genentech Inc., San Francisco, CA 94080, USA., Booler H; Department of Safety Assessment, Genentech Inc., San Francisco, CA 94080, USA., Bravo J; Department of Safety Assessment, Genentech Inc., San Francisco, CA 94080, USA., Brendza R; Department of Neuroscience, Genentech Inc., San Francisco, CA 94080, USA., Brunstein F; Department of Licensing and Early Development Safety, Genentech Inc., San Francisco, CA 94080, USA., Chan R; Department of Protein Chemistry, Genentech Inc., San Francisco, CA 94080, USA., Chandra P; Department of Clinical Pharmacology, Genentech Inc., San Francisco, CA 94080, USA., Couch JA; Project Team Leadership, Genentech Inc., San Francisco, CA 94080, USA., Datwani A; Department of Bioanalytical Sciences, Genentech Inc., San Francisco, CA 94080, USA., Demeule B; Department of Late Stage Pharmaceutical Development, Genentech Inc., San Francisco, CA 94080, USA., DiCara D; Department of Antibody Engineering, Genentech Inc., San Francisco, CA 94080, USA., Erickson R; Department of Bioanalytical Sciences, Genentech Inc., San Francisco, CA 94080, USA., Ernst JA; Department of Protein Chemistry, Genentech Inc., San Francisco, CA 94080, USA., Foreman O; Department of Pathology, Genentech Inc., San Francisco, CA 94080, USA., He D; Department of Biochemical and Cellular Pharmacology, Genentech Inc., San Francisco, CA 94080, USA., Hötzel I; Department of Antibody Engineering, Genentech Inc., San Francisco, CA 94080, USA., Keeley M; Project Team Leadership, Genentech Inc., San Francisco, CA 94080, USA., Kwok MCM; Department of Protein Chemistry, Genentech Inc., San Francisco, CA 94080, USA., Lafrance-Vanasse J; Department of Protein Chemistry, Genentech Inc., San Francisco, CA 94080, USA., Lin H; Department of Neuroscience, Genentech Inc., San Francisco, CA 94080, USA., Lu Y; Department of Biochemical and Cellular Pharmacology, Genentech Inc., San Francisco, CA 94080, USA., Luk W; Department of Biochemical and Cellular Pharmacology, Genentech Inc., San Francisco, CA 94080, USA., Manser P; Biostatistics, Genentech Inc., San Francisco, CA 94080, USA., Muhs A; AC Immune SA, EPFL Innovation Park, Building B, CH-1015 Lausanne, Switzerland., Ngu H; Department of Pathology, Genentech Inc., San Francisco, CA 94080, USA., Pfeifer A; AC Immune SA, EPFL Innovation Park, Building B, CH-1015 Lausanne, Switzerland., Pihlgren M; AC Immune SA, EPFL Innovation Park, Building B, CH-1015 Lausanne, Switzerland., Rao GK; Department of Safety Assessment, Genentech Inc., San Francisco, CA 94080, USA., Scearce-Levie K; Department of Neuroscience, Genentech Inc., San Francisco, CA 94080, USA., Schauer SP; Department of Biomarker Development, Genentech Inc., San Francisco, CA 94080, USA., Smith WB; Alliance for Multispecialty Research, University of Tennessee Medical Center, Knoxville, TN 37920, USA., Solanoy H; Department of Neuroscience, Genentech Inc., San Francisco, CA 94080, USA., Teng E; Department of Early Clinical Development, Genentech Inc., San Francisco, CA 94080, USA., Wildsmith KR; Department of Biomarker Development, Genentech Inc., San Francisco, CA 94080, USA., Bumbaca Yadav D; Department of Preclinical and Translational Pharmacokinetics and Pharmacodynamics, Genentech Inc., San Francisco, CA 94080, USA., Ying Y; Department of Bioanalytical Sciences, Genentech Inc., San Francisco, CA 94080, USA., Fuji RN; Department of Safety Assessment, Genentech Inc., San Francisco, CA 94080, USA. fuji.reina@gene.com., Kerchner GA; Department of Early Clinical Development, Genentech Inc., San Francisco, CA 94080, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2021 May 12; Vol. 13 (593).
Autor:
Bumbaca Yadav D; From the Departments of Preclinical and Translational Pharmacokinetics., Sharma VK; Late Stage Pharmaceutical Development., Boswell CA; From the Departments of Preclinical and Translational Pharmacokinetics., Hotzel I; Antibody Engineering., Tesar D; Drug Delivery, Genentech Inc., South San Francisco, California 94080., Shang Y; Antibody Engineering., Ying Y; BioAnalytical Sciences., Fischer SK; BioAnalytical Sciences., Grogan JL; Research., Chiang EY; Research., Urban K; Nonclinical Operations, and., Ulufatu S; Nonclinical Operations, and., Khawli LA; From the Departments of Preclinical and Translational Pharmacokinetics., Prabhu S; From the Departments of Preclinical and Translational Pharmacokinetics., Joseph S; From the Departments of Preclinical and Translational Pharmacokinetics., Kelley RF; Drug Delivery, Genentech Inc., South San Francisco, California 94080 kelley.bob@gene.com.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2015 Dec 11; Vol. 290 (50), pp. 29732-41. Date of Electronic Publication: 2015 Oct 21.